Recom To Present at the International Society for Computerized Electrocardiology 30th Annual Conference.

LOS ANGELES -- Recom Managed Systems, Inc. (OTCBB: RECM) announced today that it has been selected to present at the 30th Annual ISCE Conference to be held on April 12-17, 2005. The principal goal of the ISCE annual conference is to exchange information through interdisciplinary dialogs among conference participants who represent industry, academia, and health care agencies, regarding developments in the field of computerized electrocardiology. The annual conference represents an opportunity for participants in the field to present their theoretical and practical findings.

Commenting on upcoming presentation Dr. Budimir S. Drakulic, Recom's Chief Technical Officer, stated: "In the last two years we have made tremendous progress in the development and validation of our high-fidelity biomedical signal recording and processing platform. To date, we have filed five patent applications, our DIVA (Device Implementation, Validation, and Application) program is underway at Duke Clinical Research Institute, and now we are going to present our R&D findings to ECG thought leaders at the 30th ISCE conference. This conference will provide a great opportunity for Recom to introduce its technology to wider ECG community".

The Recom signal processing platform utilizes the company's patented signal technology that produces a high-fidelity ECG signal in the presence of ambulatory noise. This allows a 12-lead ambulatory recorder to produce ECG data on par with other clinical quality 12-lead modalities such as resting ECG and exercise stress testing.

About Recom Managed Systems, Inc.

Recom Managed Systems, Inc. is an emerging life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With our patented signal technology platform, Recom brings clinical quality physiological signal monitoring to the ambulatory setting.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.